COVID-19 and addiction

MJ Dubey, R Ghosh, S Chatterjee, P Biswas… - Diabetes & Metabolic …, 2020 - Elsevier
Background and aims 2019-coronavirus disease (COVID-19) is causing insurmountable
psychosocial impact on the whole mankind. Marginalized community, particularly those with …

The early impact of COVID-19 on the incidence, prevalence, and severity of alcohol use and other drugs: A systematic review

RA Schmidt, R Genois, J Jin, D Vigo, J Rehm… - Drug and alcohol …, 2021 - Elsevier
Background The aim of this paper was to examine the early impact of COVID-19 on
substance use to assess implications for planning substance use treatment and support …

Challenges posed by COVID‐19 to people who inject drugs and lessons from other outbreaks

TI Vasylyeva, P Smyrnov, S Strathdee… - African Journal of …, 2020 - journals.lww.com
Introduction: In light of the COVID-19 pandemic, considerable effort is going into identifying
and protecting those at risk. Criminalization, stigmatization and the psychological, physical …

Mental health management of elite athletes during COVID-19: a narrative review and recommendations

CL Reardon, A Bindra, C Blauwet, R Budgett… - British journal of sports …, 2021 - bjsm.bmj.com
Elite athletes suffer many mental health symptoms and disorders at rates equivalent to or
exceeding those of the general population. COVID-19 has created new strains on elite …

[HTML][HTML] Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study

C Russell, F Ali, F Nafeh, J Rehm, S LeBlanc… - Journal of substance …, 2021 - Elsevier
Introduction Closures and reductions in capacity of select health and social services in
response to the COVID-19 pandemic may have placed people who use drugs (PWUD) at a …

Addressing the syndemic of HIV, hepatitis C, overdose, and COVID-19 among people who use drugs: the potential roles for decriminalization and safe supply

M Bonn, A Palayew, S Bartlett, TD Brothers… - Journal of studies on …, 2020 - jsad.com
People who use drugs (PWUD) face concurrent public health emergencies from overdoses,
HIV, hepatitis C, and COVID-19, leading to an unprecedented syndemic. Responses to …

[HTML][HTML] Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study

MA Irvine, D Oller, J Boggis, B Bishop… - The Lancet Public …, 2022 - thelancet.com
Background The US overdose crisis is driven by fentanyl, heroin, and prescription opioids.
One evidence-based policy response has been to broaden naloxone distribution, but how …

[HTML][HTML] Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review

N Krawczyk, A Fawole, J Yang, B Tofighi - Addiction Science & Clinical …, 2021 - Springer
Background The COVID-19 pandemic has exerted a significant toll on the lives of people
who use opioids (PWUOs). At the same time, more flexible regulations around provision of …

Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19

S Brothers, A Viera, R Heimer - Journal of substance abuse treatment, 2021 - Elsevier
Background Due to the COVID-19 pandemic, the Substance Abuse and Mental Health
Services Administration (SAMHSA) has relaxed restrictions on methadone treatment in the …

Emergency department visits for nonfatal opioid overdose during the COVID-19 pandemic across six US health care systems

WE Soares III, ER Melnick, B Nath, G D'Onofrio… - Annals of Emergency …, 2022 - Elsevier
Study objective People with opioid use disorder are vulnerable to disruptions in access to
addiction treatment and social support during the COVID-19 pandemic. Our study objective …